Ritonavir inhibits NF-κB activity, and the subsequent expression of NF-κB regulated gene products and cytokines in T-cell leukemia [176] and Kaposi’s Sarcoma [177], respectively. The gene discussed is NFKB1; the disease is Kaposi's sarcoma.